APA (7th ed.) Citation

Liauw, W., Chern, B., & Shafren, D. (2012). 589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours. European Journal of Cancer, 48, 180. https://doi.org/10.1016/S0959-8049(12)72386-9

Chicago Style (17th ed.) Citation

Liauw, W., B. Chern, and D.R Shafren. "589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours." European Journal of Cancer 48 (2012): 180. https://doi.org/10.1016/S0959-8049(12)72386-9.

MLA (9th ed.) Citation

Liauw, W., et al. "589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours." European Journal of Cancer, vol. 48, 2012, p. 180, https://doi.org/10.1016/S0959-8049(12)72386-9.